C07C229/56

COMPOSITIONS AND METHODS OF TREATING RETINAL DISEASE
20190210971 · 2019-07-11 ·

Compositions and methods for treating macular degeneration and other forms of retinal disease whose etiology involves the accumulation of A2E and/or lipofuscin, and, more specifically, for preventing the formation and/or accumulation of A2E are disclosed

COMPOSITIONS AND METHODS OF TREATING RETINAL DISEASE
20190210971 · 2019-07-11 ·

Compositions and methods for treating macular degeneration and other forms of retinal disease whose etiology involves the accumulation of A2E and/or lipofuscin, and, more specifically, for preventing the formation and/or accumulation of A2E are disclosed

BENZODICYCLOALKANE DERIVATIVE, PREPARATION METHOD AND USE THEREOF

It is provided herein a benzobicycloalkane derivative, and a preparation method and use thereof. In particular, it is provided herein a compound of Formula (I), or a pharmaceutically acceptable salt, stereoisomer or solvate thereof, a preparation method, and a use thereof in preparation of drugs for treating pain.

##STR00001##

LOW TOXICITY COMPOUNDS FOR USE AS INSECTICIDES AND METHOD OF PRODUCING SAID COMPOUNDS

The present application relates to a compound of Formula (I) and its analogues, which are obtained by chemical synthesis. The disclosed compounds are suitable to be used as insecticides by killing insect cells in a selective fashion, namely by not being toxic to human cells. These compounds are different from existing insecticide solutions given their potency, selectivity and non-toxicity for human cells, and mechanism of action via caspase activation.

LOW TOXICITY COMPOUNDS FOR USE AS INSECTICIDES AND METHOD OF PRODUCING SAID COMPOUNDS

The present application relates to a compound of Formula (I) and its analogues, which are obtained by chemical synthesis. The disclosed compounds are suitable to be used as insecticides by killing insect cells in a selective fashion, namely by not being toxic to human cells. These compounds are different from existing insecticide solutions given their potency, selectivity and non-toxicity for human cells, and mechanism of action via caspase activation.

Imidazole derivatives as prodrugs of diclofenac

The present invention relates to a compound of formula (I): ##STR00001## wherein R.sub.1 is R.sub.3IPU and R.sub.2 is the acyloxy residue of diclofenac, and specified by the following structures: ##STR00002## wherein OHR.sub.3IPU is selected from ##STR00003## and R.sub.4 and R.sub.5 may be the same or different selected from H and CH.sub.3 and salts, solvates and hydrates thereof.

RETINOID COMPOUND, PREPARATION METHOD THEREFOR, INTERMEDIATES THEREOF AND APPLICATION THEREOF

Disclosed are a retinoid compound, a preparation method therefor, intermediates thereof and an application thereof. The retinoid compound I of the present invention has a good tumor growth inhibition rate.

RETINOID COMPOUND, PREPARATION METHOD THEREFOR, INTERMEDIATES THEREOF AND APPLICATION THEREOF

Disclosed are a retinoid compound, a preparation method therefor, intermediates thereof and an application thereof. The retinoid compound I of the present invention has a good tumor growth inhibition rate.

HYDROGENATION OF NITROBENZOIC ACID AND NITROBENZAMIDE

Described herein are novel reduction reactions. Compounds prepared by the methods disclosed herein are useful for preparation of certain anthranilamide compounds that are of interest as insecticides, such as, for example, the insecticides chlorantraniliprole and cyantraniliprole.

HYDROGENATION OF NITROBENZOIC ACID AND NITROBENZAMIDE

Described herein are novel reduction reactions. Compounds prepared by the methods disclosed herein are useful for preparation of certain anthranilamide compounds that are of interest as insecticides, such as, for example, the insecticides chlorantraniliprole and cyantraniliprole.